Xevinapant: Clinical Trials

2 trials of Xevinapant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Withdrawn 1

Follow Xevinapant: new trials by email Literature Review of Xevinapant trials Research Report on Xevinapant

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Biospecimen Collection, Carboplatin, Chest Radiography - Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2WithdrawnECOG-ACRIN Cancer Research Group2024-04-122024-07-25
Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Xevinapant, Placebo - Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC132023-11-152026-08-20

Conditions studied

Carcinoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

ECOG-ACRIN Cancer Research Group (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)

Countries

Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Slovenia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Heath D Skinner (1)  ·  Pierluigi Bonomo, Dr (1)  ·  Sjoukje Oosting, Dr (1)

NIH funding

U10CA180820 (1)